ROTTERDAM, Netherlands and SAN DIEGO, Oct. 24, 2024 /PRNewswire/ — SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, inflammatory, and infectious diseases, announced today the results of a comprehensive systematic review and meta-analysis conducted by Melanoma Institute of Australia (MIA).
Health Professionals
Elderly population faces escalating melanoma incidence over three decades
The prevalence and fatality rates of cutaneous malignant melanoma (CMM) have been rising, particularly among the elderly.
MMS-I Treatment Is Linked to Low Recurrence, Mortality in Head and Neck Melanoma
Mohs micrographic surgery with melanocytic immunostains (MMS-I) is emerging as an effective treatment option for invasive melanomas, particularly in anatomically constrained areas, due to a low risk of local recurrence and disease-specific mortality, according to study results published in Dermatologic Surgery.
Impact of Malignant Melanoma on Employment and Work Ability
The study underscores the importance of addressing work-related concerns for patients with melanoma, advocating for effective communication about rehabilitation options.